C75.2
Malignant neoplasm of craniopharyngeal duct
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the craniopharyngeal duct, classified under ICD-10 code C75.2, is an uncommon and aggressive type of brain tumor located near the pituitary gland. This tumor develops from abnormal cell growth along the craniopharyngeal duct, a structure that plays a role during embryonic development as it connects the developing brain to the oral cavity. Although rare, understanding this condition is important due to its potential to affect neighboring brain structures and the overall health of affected individuals.
Causes & Symptoms
Clinical Causes: Genetic mutations that lead to abnormal cell growth Previous radiation exposure to the brain region Family history of brain tumors Unknown factors; many cases have no identifiable cause
Key Symptoms: Headaches that may worsen over time Seizures or convulsions Visual disturbances, such as blurred or double vision Hormonal imbalances due to pituitary gland involvement Nausea or vomiting Difficulty with coordination or balance Changes in mental status or personality
Diagnostic & Treatment
Diagnosis Path: Diagnosing a malignant neoplasm of the craniopharyngeal duct typically involves a combination of imaging studies and medical evaluations, including: - Magnetic Resonance Imaging (MRI) to visualize the tumor's size, location, and impact on nearby structures - Computerized Tomography (CT) scans for detailed bone and tissue assessment - Blood tests to evaluate hormonal levels if the pituitary gland is affected - Biopsy procedures to obtain tissue samples for histopathological analysis, confirming malignancy Early detection is crucial to developing an effective treatment plan and managing symptoms effectively.
Treatment Protocols: Treatment options usually involve a multidisciplinary approach, which may include: - Surgical removal of the tumor, aiming to excise as much as possible while preserving vital functions - Radiation therapy to target residual tumor cells and reduce the risk of recurrence - Chemotherapy, in some cases, to address malignant aspects, though its role is limited and tailored to individual cases - Supportive therapies to manage symptoms and hormonal imbalances, such as hormone replacement therapy Each treatment plan is personalized based on the tumor's size, location, patient health, and other factors, emphasizing the importance of specialized medical care.
Clinical Advice & FAQs
Billing Guidance
Is C75.2 a billable ICD-10 code?
Yes, C75.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C75.2?
Clinical documentation must specify the nature of Malignant neoplasm of craniopharyngeal duct and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
